SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Co. is experiencing significant volatility, driven by news of a government grant revocation, which has sparked debate among investors about the company's short-term prospects. The community is actively discussing potential entry points, with some interpreting the pullback as a buying opportunity while others express concerns about the impact on the company's financial outlook. Despite the recent downturn, the stock remains a popular topic, reflecting ongoing interest in the battery technology sector.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending as traders discuss a potential short squeeze, amplified by a high short float and recent news regarding a new menopause treatment platform. Community members are actively debating the stock's potential to break through resistance levels, with some expressing concerns about valuation and potential pullbacks, while others anticipate significant growth in the digital health sector.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending due to investor day and its AI strategy, particularly Agentforce 360, sparking discussions about growth potential and partnerships. Some are optimistic about AI integrations and potential revenue boost, while others are skeptical, citing concerns over slower growth and management's actions. Community members are actively debating its valuation, competitive position against companies like Palantir, and overall market sentiment.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as traders debate whether the stock is setting up for a rebound or a further pullback, with community members actively discussing potential put opportunities. Discussions include the impact of tariffs, competition from other brands, and speculation around potential catalysts like activist investor involvement. Some traders are also pointing to large put option sweeps as a sign of bearish sentiment, while others believe the stock is oversold.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

OMER is trending following news of a deal with Novo Nordisk for its MASP-3 inhibitor, potentially worth up to $2.1 billion, which has sparked significant community discussion around short squeezes and future price targets. The community expresses optimism about Omeros' future prospects, especially regarding the potential approval of Narsoplimab and its impact on the company's valuation. Some traders are closely watching potential short squeezes given the stock's short interest.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

EOSE is trending due to renewed interest in battery technology and energy storage solutions, particularly those supporting AI infrastructure. Community members are actively discussing the potential for a short squeeze and the company's role in the AI sector, while Stifel's recent price target increase is adding to the bullish sentiment. The stock is also gaining attention as a 'Made in America' play, potentially insulated from trade tensions.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

UAL is trending as investors discuss its recent earnings and future outlook, despite mixed reactions to the report. The community is focused on whether the stock can maintain its gains following a positive run-up spurred by a competitor's strong performance, while some anticipate a pullback due to lowered guidance.

Microvast Holdings, Inc. is an advanced battery technology company. It engages in the business of designing, developing, and manufacturing battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems. The company was founded by Yang Wu on October 12, 2006 and is headquartered in Stafford, TX.

Microvast Holdings Inc

MVST is trending as investors highlight its undervalued status compared to peers in the battery sector, with many pointing to its profitability and potential for growth, especially with upcoming Q3 earnings and expansion plans; the community anticipates a continued surge, driven by institutional buying and possible short squeezes, with some suggesting a significant repricing toward fair value.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending as the community discusses recent price action and potential catalysts, including upcoming milestones for Anaphylm and speculation around partnership or buyout opportunities. Chatter revolves around increased visibility following media appearances and the potential for a significant market impact with its sublingual film technology. Some investors are drawing comparisons to a competitor's journey while others express long-term bullish sentiment.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending as investors anticipate strong earnings driven by AI and HPC demand, with some suggesting the results will act as a bellwether for the entire semiconductor sector. The community is actively discussing whether earnings will be a "buy the rumor, sell the news" event or if blowout numbers could trigger a sector-wide rally. Some also speculate on potential partnerships with companies like OpenAI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory...

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory...

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on August 30...

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.

Equillium Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$1.27
Prev Close	$1.24
Open	$1.24
Dividend Yield	0.00%
50-Day Moving Average	$1.44
Beta	1.02
Avg. Volume	1.27M
PE Ratio	-2.19

52-Week High	$2.35
52-Week Low	$0.27
Market Capitalization	$73.78M
EPS (Annual)	-$0.2282
Price to Book	8.76
Revenue Per Employee	$1.17M
Enterprise Value/EBITDA	N/A

EQ
Equillium Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EQ News

EQEquillium Inc